Singapore gets South-East Asia's first accredited cord blood bank:
This article was originally published in Clinica
The first umbilical cord blood bank in South-East Asia to receive accreditation from the prestigious, non-profit American Association of Blood Banks (AABB) is CordLife, based in Singapore. CordLife is a subsidiary of Australian cell therapy company CyGenics. It is now one of just 35 private and public cord blood banks around the world to have achieved the accreditation from the AABB and the eighth outside the US. The accreditation process, which is a time-consuming and expensive exercise, extends also into non-lab functions such as sales, marketing and HR. It is a globally recognised standard for all operating cord blood banks.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.